Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. Respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
Medical Developments International Ltd Informations sur les dividendes
Medical Developments International Ltd a un dividende annuel de 0.00 par action, avec un rendement de 0.00%. Le dividende est payé semestriellement et la dernière date d'ex-dividende était le Mar 5, 2020.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.00
Mar 5, 2020
Fréquence des paiements
Taux de distribution
Semestriellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Mar 5, 2020
$0.0271
Mar 6, 2020
Apr 17, 2020
Sep 3, 2019
$0.0271
Sep 4, 2019
Oct 4, 2019
Mar 7, 2019
$0.0271
Mar 8, 2019
Apr 17, 2019
Graphiques des dividendes
MDDVF Dividendes
MDDVF Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Medical Developments International Ltd et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Medical Developments International Ltd ?
Quelle est la date ex-dividende pour MDDVF ?
À quelle fréquence Medical Developments International Ltd verse-t-elle des dividendes ?